- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it was named a 2017 Clarivate Analytics Top 100 Global Innovator.
“We are pleased and honored to once again be recognized as a Top 100 Global Innovator by Clarivate Analytics, as it underlines our commitment to innovation,” said Frans van Houten, CEO Royal Philips. “Our EUR 1.7 billion global R&D program and strong intellectual property portfolio fuel our ability to deliver integrated solutions that improve people’s health and drive profitable growth for the company.”
“We are pleased and honored to once again be recognized as a Top 100 Global Innovator by Clarivate Analytics, as it underlines our commitment to innovation.” - Frans van Houten, CEO Royal Philips
Clarivate Analytics’ methodology for determining the Top 100 Global Innovators is based on four principles: overall patent volume, patent application-to-grant success rate, global reach of the portfolio, and patent influence as evidenced by citations. The peer-reviewed methodology was executed using Clarivate analytics-powered solutions, including the Derwent World Patents Index (DWPI). The DWPI provides editorially enhanced, authoritative and accurate patent data, and is trusted by more than 40 patent offices worldwide. To view the full list of Top 100 Global Innovators and read the report on the 2017 Clarivate Analytics Top 100 Global Innovator program, go to www.top100innovators.com.